tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
TipRanksTop Financial ExpertsInsidersJohn Peter Gutfreund

John Peter Gutfreund Insider Profile

4 Followers
John Peter Gutfreund, Former Director at OncoCyte, holds 3.82M shares in OncoCyte (Ticker: OCX).
See the Hottest Stocks Based on Insider Trading >
tipranks
John Peter Gutfreund

John Peter Gutfreund
OncoCyte (OCX)
Former Director

Ranked #87,720 out of 98,624 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-69.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$9M
100.00%
A breakdown of John Peter Gutfreund's holdings
See the Top Stocks by Insiders

Insider Roles

OncoCyte
(OCX)
Former Director
Roles that John Peter Gutfreund holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
OncoCyte
(OCX)
Rating:Informative Buy
Date:Dec 28, 2022 - Dec 28, 2023
Return:-58.30%
The most profitable trade made by John Peter Gutfreund
See the Latest Stocks Traded by Insiders

John Peter Gutfreund's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OCX
OncoCyte
Jul 03, 2023
Former Director
Uninformative Sell
―
$9.47M
Success Rate for
OCX
0 out of 2 profitable transactions on
OCX
0%
Average Return for
OCX
Average return per transaction on
OCX
-69.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 17, 2022
Uninformative Buy
$0.00
-
$0.00
―
Aug 17, 2022
Informative Buy
$23.25K
-
$0.93
-80.70%
Dec 28, 2022
Informative Buy
$24.00K
-
$0.32
-58.30%
Apr 05, 2023
Uninformative Buy
$596.75K
-
$0.35
―
Jul 03, 2023
Uninformative Sell
$0.00
-
$0.00
―
List of latest transactions for each holding click on a transaction to see John Peter Gutfreund's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

John Peter Gutfreund insider profile FAQ

What is the percentage of profitable transactions made by John Peter Gutfreund?
The percentage of profitable transactions made by John Peter Gutfreund is 0%.
    What is the average return per transaction made by John Peter Gutfreund?
    The average return per transaction made by John Peter Gutfreund is -69.50%.
      What stocks does John Peter Gutfreund hold?
      John Peter Gutfreund holds: OCX stocks.
        What was John Peter Gutfreund’s latest transaction?
        John Peter Gutfreund latest transaction was an Uninformative Sell of ―.
          What was John Peter Gutfreund's most profitable transaction?
          John Peter Gutfreund’s most profitable transaction was an Informative Buy of OCX stock on December 28, 2022. The return on the trade was -58.30%.
            What is John Peter Gutfreund's role in OncoCyte?
            John Peter Gutfreund's role in OncoCyte is Former Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.